IPAR vs VRTX · P/E 17, rev $1.32B vs P/E 30, rev $12.00B
Inter Parfums Inc (IPAR) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Inter Parfums Inc (IPAR) is a household & personal products company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported IPAR revenue for 2023-12-31 was $1.32B. Net income was $187.8M. Revenue was up 21.3% from 2022-12-31 to 2023-12-31. IPAR currently screens at market cap $2.92B and trailing P/E 17.3.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
IPAR currently screens at market cap $2.92B and trailing P/E 17.3. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the IPAR and VRTX stock pages for the full models.
Not investment advice.